Cargando…

Development and validation of a combined hypoxia and ferroptosis prognostic signature for breast cancer

BACKGROUND: Hypoxia is involved in tumor biological processes and disease progression. Ferroptosis, as a newly discovered programmed cell death process, is closely related to breast cancer (BC) occurrence and development. However, reliable prognostic signatures based on a combination of hypoxia and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Jianxin, Shen, Xi, Zhou, Junjie, Yu, Heping, Wang, Birong, Sun, Jianbin, Wang, Jing, Liu, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043308/ https://www.ncbi.nlm.nih.gov/pubmed/36998462 http://dx.doi.org/10.3389/fonc.2023.1077342

Ejemplares similares

Construction and Validation of a Combined Ferroptosis and Hypoxia Prognostic Signature for Hepatocellular Carcinoma
por: Wen, Kai, et al.
Publicado: (2021)

Establishment and validation of a ferroptosis-related prognostic signature for hepatocellular carcinoma
por: He, Yixian, et al.
Publicado: (2023)

Development and Validation of a 6-Gene Hypoxia-Related Prognostic Signature For Cholangiocarcinoma
por: Sun, Qi, et al.
Publicado: (2022)

Identification and Validation of a Prognostic Signature for Prostate Cancer Based on Ferroptosis-Related Genes
por: Liu, Huan, et al.
Publicado: (2021)

Development and validation of a hypoxia-related prognostic signature for breast cancer
por: Wang, Jianxin, et al.
Publicado: (2020)

Development and Validation of Ferroptosis- and Immune-Related lncRNAs Signatures for Breast Infiltrating Duct and Lobular Carcinoma
por: Wei, Tao, et al.
Publicado: (2022)

A Novel Ferroptosis-Related 4-Gene Prognostic Signature for Cholangiocarcinoma and Photodynamic Therapy
por: Zhang, Zi-jian, et al.
Publicado: (2021)

Autophagy-related prognostic signature characterizes tumor microenvironment and predicts response to ferroptosis in gastric cancer
por: Li, Haoran, et al.
Publicado: (2022)

A Novel Prognostic Model Based on Ferroptosis-Related Gene Signature for Bladder Cancer
por: Yang, Libo, et al.
Publicado: (2021)

Development and validation of a combined ferroptosis and immune prognostic signature for lung adenocarcinoma
por: Li, Han, et al.
Publicado: (2022)

A novel 10-gene ferroptosis-related prognostic signature in acute myeloid leukemia
por: Zhu, Kai, et al.
Publicado: (2022)

Identification of a Novel Ferroptosis-Related Gene Prognostic Signature in Bladder Cancer
por: Sun, Jiale, et al.
Publicado: (2021)

The Identification and Validation of Two Heterogenous Subtypes and a Risk Signature Based on Ferroptosis in Hepatocellular Carcinoma
por: Liu, Zaoqu, et al.
Publicado: (2021)

Development and validation of a combined hypoxia- and metabolism-related prognostic signature to predict clinical prognosis and immunotherapy responses in clear cell renal cell carcinoma
por: Wu, Xin, et al.
Publicado: (2023)

A ferroptosis-related gene signature associated with immune landscape and therapeutic response in osteosarcoma
por: Wang, Xinxing, et al.
Publicado: (2022)

Establishing a prognostic model of ferroptosis- and immune-related signatures in kidney cancer: A study based on TCGA and ICGC databases
por: Han, Zhijun, et al.
Publicado: (2022)

A Hypoxia-Associated Prognostic Gene Signature Risk Model and Prognosis Predictors in Gliomas
por: Gao, Feng, et al.
Publicado: (2021)

Development and validation of a novel hypoxia-related signature for prognostic and immunogenic evaluation in head and neck squamous cell carcinoma
por: Li, Su-Ran, et al.
Publicado: (2022)

Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma
por: Li, Wang, et al.
Publicado: (2020)

Identification and Validation of a Four-Gene Ferroptosis Signature for Predicting Overall Survival of Lung Squamous Cell Carcinoma
por: Wang, Qi, et al.
Publicado: (2022)

Identification of Novel Prognostic Risk Signatures of Soft Tissue Sarcoma Based on Ferroptosis-Related Genes
por: Huang, Wenjing, et al.
Publicado: (2021)

Development and Validation of a Prognostic Signature for Malignant Pleural Mesothelioma
por: Zhou, Jian-Guo, et al.
Publicado: (2019)

Establishment and validation of a ferroptosis-related signature predicting prognosis and immunotherapy effect in colon cancer
por: Li, Zhufeng, et al.
Publicado: (2023)

A New Prognostic Risk Signature of Eight Ferroptosis-Related Genes in the Clear Cell Renal Cell Carcinoma
por: Chen, Ji, et al.
Publicado: (2021)

Prognostic Signatures Based on Ferroptosis- and Immune-Related Genes for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma
por: Xing, Chaoqun, et al.
Publicado: (2022)

Development and Validation of a Prognostic Signature Based on Immune Genes in Cervical Cancer
por: Chen, Yu, et al.
Publicado: (2021)

A Novel Prognostic Signature Based on Ferroptosis-Related Genes Predicts the Prognosis of Patients With Advanced Bladder Urothelial Carcinoma
por: Li, Xiaoqi, et al.
Publicado: (2021)

Development and Validation of a 6-miRNA Prognostic Signature in Spinal Chordoma
por: Huang, Wei, et al.
Publicado: (2020)

A Novel Prognostic Signature Based on Glioma Essential Ferroptosis-Related Genes Predicts Clinical Outcomes and Indicates Treatment in Glioma
por: Yun, Debo, et al.
Publicado: (2022)

Identification of immunosuppressive signature subtypes and prognostic risk signatures in triple-negative breast cancer
por: Ding, Ran, et al.
Publicado: (2023)

A pyroptosis-related gene signature for prognostic and immunological evaluation in breast cancer
por: Zhong, Yue, et al.
Publicado: (2022)

Identification of m6A modification patterns and development of m6A–hypoxia prognostic signature to characterize tumor microenvironment in triple-negative breast cancer
por: Shen, Xi, et al.
Publicado: (2022)

Construction and validation of 3-genes hypoxia-related prognostic signature to predict the prognosis and therapeutic response of hepatocellular carcinoma patients
por: Liu, Yunxun, et al.
Publicado: (2023)

A novel 25-ferroptosis-related gene signature for the prognosis of gliomas
por: Peng, Xiaojiang, et al.
Publicado: (2023)

Identification and Validation of a Prognostic Signature for Thyroid Cancer Based on Ferroptosis-Related Genes
por: Wang, Yue, et al.
Publicado: (2022)

Construction and validation of a prognostic model for hepatocellular carcinoma: Inflammatory ferroptosis and mitochondrial metabolism indicate a poor prognosis
por: Han, Fang, et al.
Publicado: (2023)

Induction of Ferroptosis by Ophiopogonin-B Through Regulating the Gene Signature AURKA in NSCLC
por: Li, Liqiu, et al.
Publicado: (2022)

Development and Validation of an RNA-Seq-Based Prognostic Signature in Neuroblastoma
por: Zhou, Jian-Guo, et al.
Publicado: (2019)

Development and Validation of an Immune-Related Prognostic Signature in Cervical Cancer
por: Su, Rongjia, et al.
Publicado: (2022)

Development and Internal Validation of a Preoperative Prediction Model for Sentinel Lymph Node Status in Breast Cancer: Combining Radiomics Signature and Clinical Factors
por: Wang, Chunhua, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bs8gf5o8gu9o90megg5delupij